TY - JOUR T1 - Recommendations for the Evaluation and Management of Patients With Rheumatic Autoimmune and Inflammatory Diseases During the Reproductive Age, Pregnancy, Postpartum and Breastfeeding JO - Reumatología Clínica (English Edition) T2 - AU - Martínez López,Juan Antonio AU - García Vivar,M. Luz AU - Cáliz,Rafael AU - Freire,Mercedes AU - Galindo,María AU - Hernández,Maria Victoria AU - López Longo,Francisco Javier AU - Martínez Taboada,Víctor AU - Pego Reigosa,Jose María AU - Rubio,Esteban AU - Trujillo,Elisa AU - Vela-Casasempere,Paloma SN - 21735743 M3 - 10.1016/j.reumae.2016.05.007 DO - 10.1016/j.reumae.2016.05.007 UR - https://www.reumatologiaclinica.org/en-recommendations-for-evaluation-management-patients-articulo-S2173574317300795 AB - ObjectiveTo develop recommendations on the evaluation and management of patients with rheumatic autoimmune and inflammatory diseases during the reproductive age, pregnancy, post-partum and breastfeeding based on the best evidence and experience. MethodsRecommendations were generated using nominal group and Delphi techniques. An expert panel of 12 rheumatologists was established. A systematic literature review and a narrative review (websites, clinical guidelines and other relevant documentation) were performed and presented to the panel in its 1st meeting to be discussed and to help define recommendations. A first draft of recommendations was generated and circulated for comments and wording refinement. A national survey analyzing different aspects of this topic was undertaken separately, followed by a Delphi process (2 rounds). Agreement with each recommendation was ranked on a scale of 1 (total disagreement) to 10 (total agreement), and was considered to be achieved if at least 70% voted ≥7. The level of evidence and grade of recommendation were assessed using the Oxford Centre for Evidence-based Medicine Levels of Evidence. ResultsA total of 14 recommendations were generated for the preconception period (oral and hormonal contraception, reproductive techniques), pregnancy (planning, treatment and follow-up), and breastfeeding (treatment and follow-up). High-risk situations such as lupus or antiphospholipid syndrome were included. A consensus >90% was reached for all but one recommendation. ConclusionsThese recommendations are intended to provide rheumatologists, patients, families and other stakeholders with a consensus on the evaluation and management of patients with autoimmune and inflammatory diseases during the reproductive age, pregnancy, postpartum and breastfeeding. ER -